Osaic Holdings’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Buy
10,559
+32
+0.3% +$543 ﹤0.01% 4138
2025
Q4
$141K Sell
10,527
-1,075
-9% -$13.3K ﹤0.01% 4423
2025
Q3
$126K Sell
11,602
-5,849
-34% -$54.5K ﹤0.01% 4588
2025
Q2
$113K Sell
17,451
-72
-0.4% -$474 ﹤0.01% 4407
2025
Q1
$103K Buy
17,523
+7,277
+71% +$52.1K ﹤0.01% 4150
2024
Q4
$71.2K Buy
10,246
+2,270
+28% +$15.6K ﹤0.01% 4430
2024
Q3
$45.4K Buy
7,976
+3,742
+88% +$26K ﹤0.01% 4819
2024
Q2
$30.5K Buy
4,234
+493
+13% +$4.31K ﹤0.01% 5047
2024
Q1
$35.2K Buy
3,741
+464
+14% +$2.65K ﹤0.01% 4977
2023
Q4
$12K Sell
3,277
-1,638
-33% -$4.93K ﹤0.01% 5745
2023
Q3
$15.4K Buy
4,915
+1,152
+31% +$4.74K ﹤0.01% 5691
2023
Q2
$13.5K Sell
3,763
-311
-8% -$1.07K ﹤0.01% 5809
2023
Q1
$12.9K Sell
4,074
-25
-0.6% -$83 ﹤0.01% 5823
2022
Q4
$9.4K Buy
4,099
+2,308
+129% +$6.41K ﹤0.01% 5971
2022
Q3
$6K Buy
1,791
+424
+31% +$4.07K ﹤0.01% 6282
2022
Q2
$13K Buy
1,367
+858
+169% +$10.9K ﹤0.01% 5905
2022
Q1
$9K Sell
509
-393
-44% -$6.82K ﹤0.01% 6211
2021
Q4
$19K Sell
902
-3,984
-82% -$127K ﹤0.01% 5832
2021
Q3
$172K Buy
4,886
+2,467
+102% +$107K ﹤0.01% 4040
2021
Q2
$124K Buy
+2,419
New +$127K ﹤0.01% 4296

Other funds holding DFTX

Osaic Holdings's DFTX Position: Q1 2026 in Review

Osaic Holdings increased its Definium Therapeutics (DFTX) stake by 0.3% in Q1 2026, buying an estimated $543 and bringing the position to 10,559 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #4138.

Osaic Holdings first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Osaic Holdings held 10,559 shares of Definium Therapeutics worth $200K as of Q1 2026.
  • Osaic Holdings bought 32 Definium Therapeutics shares in Q1 2026, an estimated $543.
  • Definium Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4138 holding.
  • Osaic Holdings first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.